Notably, BCAT1 promotes BCAA production in BCR-ABL driven chronic myelogenous leukemia, in which BCAT1 blockade impairs B-cell proliferation and causes differentiation77. The gene discussed is BCAT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.